MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
- 1 April 1998
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 5, S86-S89
- https://doi.org/10.1016/s1076-6332(98)80069-x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Evaluation of the hepatocyte-specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat modelJournal of Magnetic Resonance Imaging, 1997
- Hepatic transport of gadobenate dimeglumine in TR− ratsAcademic Radiology, 1996
- LIVER III: GADOLINIUM-BASED HEPATOBILIARY CONTRAST AGENTS (Gd-EOB-DTPA AND Gd-BOPTA/Dimeg)Magnetic Resonance Imaging Clinics of North America, 1996
- Binding of Gadobenate Dimeglumine to Proteins Extravasated into Interstitial Space Enhances Conspicuity of Reperfused InfarctsInvestigative Radiology, 1994
- Interim Results of Phase II Clinical Testing of Gadobenate DimeglumineInvestigative Radiology, 1994
- Soluble‐type hepatobiliary contrast agents for MR imagingJournal of Magnetic Resonance Imaging, 1993
- Gd-BOPTA/Dimeg: Experimental disease imagingMagnetic Resonance in Medicine, 1991